View in EDS

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.

Saved in:
Bibliographic Details
Title: The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
Authors: Volkmann A; Bavarian Nordic, Germany., Williamson AL; Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa., Weidenthaler H; Bavarian Nordic, Germany., Meyer TPH; Bavarian Nordic, Germany., Robertson JS; Independent Adviser, United Kingdom., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA., Evans E; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA., Smith ER; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA., Chen RT; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA.
Corporate Authors: Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG
Source: Vaccine [Vaccine] 2021 May 21; Vol. 39 (22), pp. 3067-3080. Date of Electronic Publication: 2020 Oct 17.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33077299
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Volkmann+A%22">Volkmann A</searchLink>; Bavarian Nordic, Germany.<br /><searchLink fieldCode="AU" term="%22Williamson+AL%22">Williamson AL</searchLink>; Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Weidenthaler+H%22">Weidenthaler H</searchLink>; Bavarian Nordic, Germany.<br /><searchLink fieldCode="AU" term="%22Meyer+TPH%22">Meyer TPH</searchLink>; Bavarian Nordic, Germany.<br /><searchLink fieldCode="AU" term="%22Robertson+JS%22">Robertson JS</searchLink>; Independent Adviser, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Excler+JL%22">Excler JL</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Condit+RC%22">Condit RC</searchLink>; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA.<br /><searchLink fieldCode="AU" term="%22Evans+E%22">Evans E</searchLink>; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Smith+ER%22">Smith ER</searchLink>; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org.<br /><searchLink fieldCode="AU" term="%22Kim+D%22">Kim D</searchLink>; Janssen Pharmaceuticals, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chen+RT%22">Chen RT</searchLink>; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Brighton+Collaboration+Viral+Vector+Vaccines+Safety+Working+Group+V3SWG%22">Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2021 May 21; Vol. 39 (22), pp. 3067-3080. <i>Date of Electronic Publication: </i>2020 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33077299
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2020.08.050
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3067
    Titles:
      – TitleFull: The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Volkmann A
      – PersonEntity:
          Name:
            NameFull: Williamson AL
      – PersonEntity:
          Name:
            NameFull: Weidenthaler H
      – PersonEntity:
          Name:
            NameFull: Meyer TPH
      – PersonEntity:
          Name:
            NameFull: Robertson JS
      – PersonEntity:
          Name:
            NameFull: Excler JL
      – PersonEntity:
          Name:
            NameFull: Condit RC
      – PersonEntity:
          Name:
            NameFull: Evans E
      – PersonEntity:
          Name:
            NameFull: Smith ER
      – PersonEntity:
          Name:
            NameFull: Kim D
      – PersonEntity:
          Name:
            NameFull: Chen RT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 05
              Text: 2021 May 21
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1